Swe
Case Summary - April Swe
[Federal Register: February 16, 2006 (Volume 71, Number 32)]
[Notices]
[Page 8304]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16fe06-70]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
ACTION: Notice.
SUMMARY: Notice is hereby given that on January 13, 2006, the
Department of Health and Human Services (HHS) Debarring Official, on
behalf of the Secretary of HHS, issued a final notice of debarment
based on the research misconduct findings of the U.S. Public Health
Service (PHS) in the following case:
April Swe, University of Wisconsin-Madison: Based on the report of
an investigation conducted by the University of Wisconsin-Madison (UWM)
and additional analysis conducted by the Office of Research Integrity
(ORI) in its oversight review, PHS found that Ms. Swe, former graduate
student at UWM, engaged in research misconduct by fabricating data on
thirty-nine (39) questionnaires of sibling human subjects associated
with an autism study. The research was supported by National Institute
on Aging, National Institutes of Health (NIH), grant R01 AG08768.
In a final decision dated January 13, 2006, the HHS Debarring
Official, on behalf of the Secretary of HHS, issued the final debarment
notice based on the PHS findings of research misconduct. The following administrative actions have been implemented for a period of three (3)
years, beginning on January 13, 2006:
(1) Ms. Swe has been debarred from eligibility for or involvement
as a principal in nonprocurement transactions (e.g., grants and
cooperative agreements) of the Federal Government and from contracting
or subcontracting with any Federal Government agency, except as
provided in 45 CFR 76.120. This action is being taken pursuant to the
debarment regulations at 45 CFR part 76.
(2) Ms. Swe has been prohibited from serving in any advisory
capacity to PHS including but not limited to service on any PHS
advisory committee, board, and/or peer review committee, or as
consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Research
Investigations
Office of Research Integrity
1101 Wootton Parkway,
Suite 750
Rockville, MD 20852
(240) 453-8800
Chris B. Pascal,Director
Office of Research Integrity.
|
Assurance
